Ionis Pharmaceuticals (IONS) Insider Trading & Ownership $42.36 +0.85 (+2.05%) (As of 09/18/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Ionis Pharmaceuticals (NASDAQ:IONS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.71%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)11Amount OfInsider Selling(Last 12 Months)$14.12 M Get IONS Insider Trade Alerts Want to know when executives and insiders are buying or selling Ionis Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address IONS Insider Buying and Selling by Quarter Ad Porter & CompanyWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. Ionis Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/28/2024Richard S GearyEVPSell320$49.16$15,731.20 8/5/2024Richard S GearyEVPSell2,430$48.00$116,640.00 7/16/2024Joseph Klein IIIDirectorSell12,000$50.00$600,000.00 5/3/2024Joseph Klein IIIDirectorSell6,000$42.71$256,260.00 4/16/2024Joseph BaroldiEVPSell4,006$41.60$166,649.60 2/16/2024Brett P MoniaCEOSell387$44.49$17,217.63 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 2/2/2024Brett P MoniaCEOSell23,501$49.37$1,160,244.37 2/2/2024Elizabeth L HougenCFOSell2,125$49.54$105,272.50 2/2/2024Eric SwayzeEVPSell1,907$49.56$94,510.92 1/31/2024Eric SwayzeEVPSell10,773$52.00$560,196.00 1/25/2024Brett P MoniaCEOSell2,285$51.75$118,248.75 1/25/2024Patrick R O'neilEVPSell6,450$51.75$333,787.50 1/17/2024Brett P MoniaCEOSell32,059$50.42$1,616,414.78 1/17/2024Elizabeth L HougenCFOSell8,683$50.42$437,796.86 1/17/2024Onaiza Cadoret-ManierEVPSell5,564$50.42$280,536.88 1/12/2024Eugene SchneiderEVPSell8,000$53.50$428,000.00 12/28/2023B Lynne ParshallDirectorSell42,525$50.19$2,134,329.75 12/26/2023B Lynne ParshallDirectorSell25,113$51.46$1,292,314.98 12/26/2023Patrick R O'neilEVPSell20,825$51.46$1,071,654.50 12/21/2023Brett P MoniaCEOSell17,500$49.29$862,575.00 12/20/2023C Frank BennettEVPSell6,500$49.64$322,660.00 12/14/2023Brett P MoniaCEOSell24,000$49.58$1,189,920.00 11/15/2023Joseph Klein IIIDirectorSell2,000$50.00$100,000.00 10/17/2023Eric SwayzeEVPSell52$47.95$2,493.40 10/12/2023Brett P MoniaCEOSell3,770$46.00$173,420.00 9/28/2023C Frank BennettEVPSell4,460$46.50$207,390.00 9/26/2023B Lynne ParshallDirectorSell10,000$45.13$451,300.00 (Data available from 1/1/2013 forward) IONS Insider Trading Activity - Frequently Asked Questions Who is on Ionis Pharmaceuticals's Insider Roster? The list of insiders at Ionis Pharmaceuticals includes Allene M Diaz, B Lynne Parshall, Brett P Monia, Brian Birchler, C Frank Bennett, Elizabeth L Hougen, Eric Swayze, Eugene Schneider, Joseph Baroldi, Joseph Klein III, Onaiza Cadoret-Manier, Patrick R O'neil, and Richard S Geary. Learn more on insiders at IONS. What percentage of Ionis Pharmaceuticals stock is owned by insiders? 2.71% of Ionis Pharmaceuticals stock is owned by insiders. Learn more on IONS's insider holdings. Which Ionis Pharmaceuticals insiders have been selling company stock? The following insiders have sold IONS shares in the last 24 months: Allene M Diaz ($26,969.85), B Lynne Parshall ($3,877,944.73), Brett P Monia ($8,116,838.90), Brian Birchler ($24,528.00), C Frank Bennett ($530,050.00), Elizabeth L Hougen ($956,171.97), Eric Swayze ($955,010.11), Eugene Schneider ($428,000.00), Joseph Baroldi ($166,649.60), Joseph Klein III ($1,185,570.00), Onaiza Cadoret-Manier ($280,536.88), Patrick R O'neil ($1,646,507.90), and Richard S Geary ($132,371.20). How much insider selling is happening at Ionis Pharmaceuticals? Insiders have sold a total of 387,249 Ionis Pharmaceuticals shares in the last 24 months for a total of $18,327,149.14 sold. More Insider Trading Tools from MarketBeat Related Companies: JAZZ Insider Buying RARE Insider Buying PRGO Insider Buying BHVN Insider Buying ACAD Insider Buying ARWR Insider Buying BHC Insider Buying BMRN Insider Buying UTHR Insider Buying INCY Insider Buying Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: This Is the Top Large-Cap Stock Insiders Are BuyingMatador Resources Insiders Keep Buying Its Stock, Should You?Top 3 Small-Cap Stocks Insiders Are Buying Right Now3 Small Cap Stocks That Insiders Are BuyingMGM Insiders Bet Big on Its Undervalued Stock This page (NASDAQ:IONS) was last updated on 9/18/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored625,000% GainThe recent crypto correction has shaken many investors, causing panic and uncertainty. But while others are fr...Crypto Swap Profits | SponsoredThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start ...Greenlane | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ionis Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ionis Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
